Experience
Allergan USA, Inc.; Pierre Fabre Medicament SAS
Prinston Pharmaceutical Inc.
Represented Allergan and Pierre Fabre in ANDA litigation in the District of New Jersey against multiple generic drug manufacturers seeking to make a generic version of Fetzima® (levomilnacipran) for the treatment of major depressive disorder.
Allergan USA, Inc.; Pierre Fabre Medicament SAS v. Prinston Pharmaceutical Inc., 2:17-cv-10230, D.N.J., Judges Mannion, Salas
Bausch & Lomb Incorporated et al
Valeant Pharmaceuticals Int’l, Inc. v. Mylan Pharmaceuticals, Inc.
Valeant; Salix; Progenics
Dow Pharmaceutical Sciences, Inc. v. Taro Pharmaceuticals U.S.A., Inc.
Dow Pharmaceutical Sciences, Inc.; Valeant
Delavau, LLC, v. J.M. Huber Corporation
J.M. Huber Corp.
Becton, Dickinson and Co. v. Insulet Corp.
Becton Dickinson & Company
L'Oreal S.A. v. Clairol Inc. and Estee Lauder, Inc.
L'Oreal, S.A.
Valeant Pharmaceuticals NA, LLC v. Zydus Pharmaceuticals, Inc.
Valeant Pharmaceuticals NA, LLC
Ferring B.V. v. Watson Laboratories, Inc.
Ferring B.V.
Astellas US LLC v. Nycomed US Inc.
Astellas US LLC
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.
We use cookies on this website to provide you with the best user experience. By accepting cookies, you agree to our use of cookies. Please note that if you opt not to accept or if you disable cookies, the “Your Finnegan” feature on this website will be disabled as well. For more information on how we use cookies, please see our Privacy Policy.
Finnegan is thrilled to announce the launch of our new blog, Ad Law Buzz, devoted solely to breaking news, developments, trends, and analysis in advertising law.